TIMP1 and prostate carcinoma: In addition to Figure 1A, studies have shown that TIMP-1 levels in plasma of prostate cancer patients are elevated and the elevated TIMP-1 levels predict for decreased survival of castration-resistant (CR) prostate cancer patients [25,38].